FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG).

Saved in:
Bibliographic Details
Title: FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG).
Authors: Kalem, Ali1 (AUTHOR) kalemali88@gmail.com, Kus, Tulay1,2 (AUTHOR), Sahin, Taha Koray2,3 (AUTHOR), Dizdar, Omer2,4 (AUTHOR), Efil, Safa Can3,5 (AUTHOR), Sendur, Mehmet Ali Nahit3,6 (AUTHOR), Aykut, Talat4,7 (AUTHOR), Araz, Murat4,8 (AUTHOR), Bolek, Hatice5,9 (AUTHOR), Urun, Yuksel5,10 (AUTHOR), Sever, Nadiye6,11 (AUTHOR), Bayoglu, Ibrahim Vedat6,12 (AUTHOR), Cavdar, Eyyup7,13 (AUTHOR), Sagıroglu, Muhammed Fatih8,14 (AUTHOR), Gunes, Tugce Kubra9,15 (AUTHOR), Ozcelik, Melike9,16 (AUTHOR), Demirel, Nadide1,10 (AUTHOR), Yıldız, Bulent2,10 (AUTHOR), Karabuga, Berkan3,11 (AUTHOR), Yalcıntas Arslan, Ulku4,11 (AUTHOR)
Source: Cancers. Sep2025, Vol. 17 Issue 17, p2730. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers17172730